The decrease in OD_320nm over time in spectrophotometric ATPase activity assays. by Kai-Yin Chau (18504230)

PP2A inhibition decreases ACS5 accumulation. by Kyle R. Skottke (223882)

Ethanol withdrawal (EW) decreases GluN2A subunit levels. by Marina Rubio (345805)

“…<p>NMDA subunit protein levels measured by Western blot analysis: GluN2A levels (B) decrease during ethanol withdrawal, whereas the levels of GluN1 (A) and GluN2B (C) remain unaltered. …”

TUDCA decreases ER stress in HOX neonatal rat lungs. by Kirkwood A. Pritchard Jr. (13449794)

“…<p>(<b>A</b>) The expression levels of ER stress markers (P-PERK 0.6±0.1-fold, p<0.001, n = 5; PERK 0.7±0.1-fold, p = 0.00364, n = 5; P-IRE1α 0.6±0.0-fold, p<0.001, n = 5; IRE1α 0.6±0.1-fold, p<0.001, n = 5; GRP78 0.8±0.1-fold, p<0.001, n = 5; cleaved ATF6 0.1±0.0-fold, p<0.001, n = 5; spliced XBP1 0.3±0.0-fold, p<0.001, n = 5; 2 males and 3 females) are all decreased while the N-glycosylated VEGFR2 is increased (3.5±0.2-fold, p<0.001, n = 5) in HOX neonatal lungs at P10 indicating TUDCA can attenuate hyperoxia-induced ER stress. …”

HDACi decrease NK function. by Matthew Pace (2954127)

A decrease in the relative absorbance (λ = 412 nm) of the colored solution formed in the reaction of free SH groups present in GAPDH with DTNB. by Joanna Gerszon (4732971)

CYP3A94 activity is significantly increased in V79-CYP3A94/DD-POR cells, but decreases after incubation with Shield-1. by Ramona Dettwiler (664360)

Data_Sheet_1_Electroconvulsive therapy triggers a reversible decrease in brain N-acetylaspartate.pdf by Vera J. Erchinger (16239980)

“…We hypothesized that disruption of neuronal networks could trigger biochemical alterations leading to a temporary decrease in N-acetylaspartate (tNAA, considered a marker of neuronal integrity), while choline (a membrane component), myo-Inositol (mI, astroglia marker), and glutamate/glutamine (Glx, excitatory neurotransmitter) were postulated to increase. …”

Chemical Inhibition of eEF1A-1 Peptide Elongation Activity Decreases Palmitate-Induced Cell Death. by Alexandra M. Stoianov (759321)

EMBS-treated cells undergo apoptosis correlated with decreased cell viability, metabolic activity and mitochondrial membrane potential. by Michelle Helen Visagie (3927308)

LPS decreases only T cell proliferative response to OKT3. by Fanny Poujol (834338)

Decreased mTOR expression. by Sandra Müller-Krebs (485766)

“…<p>Western blot analysis of podocytes showing decreased expression of total mTOR protein with increasing concentrations (0–100 nM) of EVL and SRL after 48 h of incubation, respectively (A, B); no differences in mTOR expression analyzing EVL and SRL (20 nM) simultaneously (C); α-tubulin served as loading control. mTOR = mammalian target of rapamycin; EVL = Everolimus; SRL = Sirolimus; C_Ø = untreated control; C = solvent ethanol control; PAN = puromycin aminonucleoside.…”

Knockdown of FZD10 results in a decrease in cell proliferation in the neural tube. by Abdulmajeed Fahad Alrefaei (8968607)

“…(F) Quantification of the number of pH3 positive cells per section in the neural tube electroporated with FZD10 shRNA vector compared to the non-electroporated side showed that there was a statistically significant decrease in the number of pH3 positive cells (students t-test (paired)).…”

ATG 5 down-regulation decreases human A53T ASYN-induced death in rat cortical neurons. by Maria Xilouri (264240)

Sleep is decreased in TBI survivors. by Bart van Alphen (12003724)

“…Sleep data for survivors is shown here. <b>(A1–3)</b> Total sleep during the day, night and total sleep shows that post-TBI is mostly decreased during the night, for up to 4 days post TBI. …”

BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion by Saeed Katiraei (3956147)

Ethanol withdrawal (EW) decreases GluN2A mRNA levels. by Marina Rubio (345805)

Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

“…MMP-2 mRNA levels were decreased with corticosterone treatment (A) (p = 0.006, n = 5). …”

Genes whose expression was decreased by 1 mM ouabain by more than 2-fold. by Larisa V. Smolyaninova (3600053)

Substance P decreases PRL immunoreactivity in human epidermis. by Ewan A. Langan (405804)

“…PRL IR was measured using Image J software, showing that (C) epidermal PRL IR was significantly decreased by 100 nM Substance P treatment (p = 0.009). …”